DE69614149D1 - Chinolinderivate als antimalariamittel - Google Patents

Chinolinderivate als antimalariamittel

Info

Publication number
DE69614149D1
DE69614149D1 DE69614149T DE69614149T DE69614149D1 DE 69614149 D1 DE69614149 D1 DE 69614149D1 DE 69614149 T DE69614149 T DE 69614149T DE 69614149 T DE69614149 T DE 69614149T DE 69614149 D1 DE69614149 D1 DE 69614149D1
Authority
DE
Germany
Prior art keywords
quinoline derivatives
antimalarial agents
antimalarial
agents
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69614149T
Other languages
English (en)
Other versions
DE69614149T2 (de
Inventor
Werner Hofheinz
Raffaello Masciadri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69614149D1 publication Critical patent/DE69614149D1/de
Publication of DE69614149T2 publication Critical patent/DE69614149T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
DE69614149T 1995-11-16 1996-11-07 Chinolinderivate als antimalariamittel Expired - Fee Related DE69614149T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH325095 1995-11-16
PCT/EP1996/004866 WO1997018193A1 (en) 1995-11-16 1996-11-07 Antimalarial quinolin derivatives

Publications (2)

Publication Number Publication Date
DE69614149D1 true DE69614149D1 (de) 2001-08-30
DE69614149T2 DE69614149T2 (de) 2002-03-14

Family

ID=4251904

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614149T Expired - Fee Related DE69614149T2 (de) 1995-11-16 1996-11-07 Chinolinderivate als antimalariamittel

Country Status (17)

Country Link
US (1) US5948791A (de)
EP (1) EP0876346B1 (de)
JP (1) JP3034609B2 (de)
KR (1) KR100263802B1 (de)
CN (1) CN1166639C (de)
AT (1) ATE203519T1 (de)
AU (1) AU718932B2 (de)
BR (1) BR9611727A (de)
CA (1) CA2237997A1 (de)
DE (1) DE69614149T2 (de)
DK (1) DK0876346T3 (de)
ES (1) ES2162110T3 (de)
GR (1) GR3037018T3 (de)
MX (1) MX9803827A (de)
PT (1) PT876346E (de)
TR (1) TR199800854T2 (de)
WO (1) WO1997018193A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE431141T1 (de) 1999-07-13 2009-05-15 Alpha Res Group Llc Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
FR2807433B1 (fr) * 2000-04-06 2002-09-20 Centre Nat Rech Scient Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
WO2003070244A1 (en) * 2002-02-22 2003-08-28 Abbott Laboratories Antagonist of melanin concentrating hormone and their uses
US6818772B2 (en) 2002-02-22 2004-11-16 Abbott Laboratories Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
US7084157B2 (en) * 2002-05-17 2006-08-01 Rajeev Raut Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
US20060014786A1 (en) * 2002-05-17 2006-01-19 Rajeev Raut Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
US7108992B2 (en) * 2002-11-27 2006-09-19 St. Jude Children's Research Hospital ATM kinase compositions and methods
WO2006088541A2 (en) 2005-02-17 2006-08-24 State Of Oregon Acting By & Through The State Board Of Higher Edu. On Behalf Of Portland State Unv. Quinoline derivatives and uses thereof
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
FR2902100A1 (fr) * 2006-06-13 2007-12-14 Sanofi Aventis Sa Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
US8481543B2 (en) 2008-11-18 2013-07-09 Oregon Health & Science University Compounds for treating parasitic disease
GB201206280D0 (en) * 2012-04-10 2012-05-23 Univ Dundee Anti-malarial agents
JPWO2015133280A1 (ja) * 2014-03-03 2017-04-06 公立大学法人名古屋市立大学 抗マラリア活性化合物及び抗マラリア薬
US20230416786A1 (en) 2020-11-30 2023-12-28 Cellectis Sa Use of aminoquinoline compounds for higher gene integration
WO2022191092A1 (ja) * 2021-03-12 2022-09-15 国立大学法人東北大学 キノリン化合物、ｈｎｍｔ阻害剤、及びａｄｈｄ、ナルコレプシー又はアルツハイマーの予防・治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816893A (en) * 1957-12-17 Improvements in or relating to
US2901484A (en) * 1957-03-04 1959-08-25 Abbott Lab Bis-quinoliniums
US3126384A (en) * 1961-05-26 1964-03-24 X-quinolyl-aminoalkylamino
US5510356A (en) * 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria
EP0765313B1 (de) * 1994-06-17 2003-08-20 F. Hoffmann-La Roche Ag N,n'-bis(chinolin-4-yl)-diamin derivate, deren herstellung und deren verwendung als antimalaria-mittel
AU2671895A (en) * 1994-06-17 1996-01-15 F. Hoffmann-La Roche Ag Bisquinolines for the treatment of malaria

Also Published As

Publication number Publication date
CN1166639C (zh) 2004-09-15
AU7566996A (en) 1997-06-05
ES2162110T3 (es) 2001-12-16
CA2237997A1 (en) 1997-05-22
ATE203519T1 (de) 2001-08-15
BR9611727A (pt) 1999-05-25
DE69614149T2 (de) 2002-03-14
DK0876346T3 (da) 2001-11-12
KR100263802B1 (ko) 2001-01-15
US5948791A (en) 1999-09-07
TR199800854T2 (xx) 1998-08-21
EP0876346A1 (de) 1998-11-11
AU718932B2 (en) 2000-05-04
PT876346E (pt) 2002-01-30
MX9803827A (es) 1998-09-30
JPH11500749A (ja) 1999-01-19
WO1997018193A1 (en) 1997-05-22
CN1202155A (zh) 1998-12-16
KR19990067646A (ko) 1999-08-25
GR3037018T3 (en) 2002-01-31
EP0876346B1 (de) 2001-07-25
JP3034609B2 (ja) 2000-04-17

Similar Documents

Publication Publication Date Title
DE69614149D1 (de) Chinolinderivate als antimalariamittel
DE69907977D1 (de) Pyrrolobenzodiazepine
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
HN1996000082A (es) Compuestos de quinolina y quinozssolina utiles en terapia.
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
DE69634416D1 (de) Chinolin-derivate
ATA204894A (de) Isochinoline
BR9711586A (pt) Compostos e uso dos mesmo
HN1998000002A (es) Compuestos de quinolina y de quinazolina utiles en terapia
ATE167670T1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
FI943100A (fi) Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ATE230718T1 (de) Beta-alkoxyacrylate gegen malaria
ATE204255T1 (de) Carbostyrilderivate als antithrombotische mittel
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
DE59608611D1 (de) Topische aciclovir-zubereitung
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
KR950007818U (ko) 멜빵용 상의
KR950008161U (ko) 개인용 찜질사우나

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee